Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resource-Adapted Triage Strategies for Women Testing HPV Positive With Self-Collected Vaginal Samples in Cameroon.

International journal of cancer·2026
Same author

[Episiotomy : what are its indications in the era of restrictive use ?]

Revue medicale suisse·2026
Same author

Systematic Review Evaluating the Influence of Veneering Design on the Clinical Outcome of All-Ceramic Implant-Supported 3-4 Units and Full Arch Fixed Dental Prostheses.

Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.]·2026
Same author

Non-Pharmaceutical Interventions on COVID-19 in Workers and Residents of Nursing Homes in Geneva: A Mixed Qualitative and Quantitative Study.

Epidemiologia (Basel, Switzerland)·2025
Same author

Barriers and Facilitators to the Preadoption of a Computer-Aided Diagnosis Tool for Cervical Cancer: Qualitative Study on Health Care Providers' Perspectives in Western Cameroon.

JMIR cancer·2025
Same author

Fertility and Miscarriage Incidence After Cervical Intraepithelial Neoplasia Treatment by Thermal Ablation: A Cohort Study.

BJOG : an international journal of obstetrics and gynaecology·2024

Related Experiment Video

Updated: Jan 14, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

[HPV self-sampling and cervical cancer screening].

Micol Murtas1, Louise Rolland-Guillard2, Ketty Hu1

  • 1Service de gynécologie, Département de la femme, de l'enfant et de l'adolescent, Hôpitaux universitaires de Genève, 1211 Genève 14.

Revue Medicale Suisse
|October 17, 2025
PubMed
Summary
This summary is machine-generated.

Human papillomavirus (HPV) self-sampling can significantly boost cervical cancer (CC) screening coverage in underscreened populations. This approach is vital for meeting global health goals and improving CC prevention strategies.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K

Related Experiment Videos

Last Updated: Jan 14, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K

Area of Science:

  • Oncology
  • Public Health
  • Infectious Diseases

Background:

  • Carcinogenic human papillomavirus (HPV) infections are the primary cause of cervical cancer (CC).
  • While vaccination is key for primary prevention, screening remains crucial for early detection.
  • Current screening methods like cytology have limitations in sensitivity compared to HPV testing.

Purpose of the Study:

  • To review the current landscape of cervical cancer screening in Switzerland and Europe.
  • To highlight the potential of HPV self-sampling to improve screening coverage, particularly for underscreened populations.
  • To assess the feasibility of implementing HPV self-sampling in Switzerland to align with World Health Organization targets.

Main Methods:

  • Literature review of cervical cancer screening strategies in Europe and Switzerland.
  • Analysis of HPV testing and self-sampling adoption in various European countries.
  • Examination of screening coverage gaps and the impact of opportunistic screening in Switzerland.

Main Results:

  • HPV testing is more sensitive than cytology and recommended as a primary screening method in several European nations.
  • HPV self-sampling has demonstrated potential to increase screening coverage by up to 2.5-fold in women aged 30 and older.
  • Switzerland faces challenges with 30% of women remaining under- or unscreened due to opportunistic screening and limited reimbursement for HPV testing.

Conclusions:

  • Implementing HPV self-sampling for underscreened women in Switzerland could significantly improve CC screening rates.
  • This strategy aligns with the World Health Organization's global goals for cervical cancer elimination.
  • Expanding access to HPV self-sampling is a critical step towards enhancing cervical cancer prevention and control.